Literature DB >> 192268

Human skin collagenase: isolation of precursor and active forms from both fibroblast and organ cultures.

G P Stricklin, E A Bauer, J J Jeffrey, A Z Eisen.   

Abstract

Human skin procollagenase has been isolated, in pure form, from the medium of fibroblasts cultured in the presence or absence of added serum. Purification was achieved using a combination of cation-exchange (phosphocellulose or carboxymethylcellulose) and gel-filtration chromatography. Two forms (60 000 and 55 000 daltons) of the procollagenase were detected by electrophoresis in sodium dodecyl sulfatepolyacrylamide gels and could be separated by chromatography on Ultrogel AcA-44. Each form was converted to active enzyme by trypsin, producing species of 50 000 and 45 000 daltons, respectively. An autoactivation process also occurred, which yielded active enzyme without a detectable change in molecular weight. Procollagenase also was found in organ cultures of human skin but only when serum was added to the medium. This suggests that a serum-inhibitable proteolytic system is present in these cultures which, like trypsin, converts procollagenase to the active enzyme forms that can be isolated from serum-free organ culture medium. The collagenase species obtained from either fibroblast or organ culture medium were chromatographically and electrophoretically identical.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 192268     DOI: 10.1021/bi00627a013

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  62 in total

1.  Identification of Clostridium histolyticum collagenase hyperreactive sites in type I, II, and III collagens: lack of correlation with local triple helical stability.

Authors:  M F French; A Bhown; H E Van Wart
Journal:  J Protein Chem       Date:  1992-02

2.  Increased expression levels of integrin alphavbeta5 on scleroderma fibroblasts.

Authors:  Yoshihide Asano; Hironobu Ihn; Kenichi Yamane; Masahide Kubo; Kunihiko Tamaki
Journal:  Am J Pathol       Date:  2004-04       Impact factor: 4.307

3.  Comparison of different methods for the isolation of mesenchymal stem cells from human umbilical cord Wharton's jelly.

Authors:  Parvin Salehinejad; Noorjahan Banu Alitheen; Abdul Manaf Ali; Abdul Rahman Omar; Maryam Mohit; Ehsan Janzamin; Fazel Sahraneshin Samani; Zahra Torshizi; Seyed Noureddin Nematollahi-Mahani
Journal:  In Vitro Cell Dev Biol Anim       Date:  2012-01-25       Impact factor: 2.416

4.  Thermal stability of human-fibroblast-collagenase-cleavage products of type-I and type-III collagens.

Authors:  C C Danielsen
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

5.  Aprotinin inhibits unspecific degradation of collagen in rat and human pancreas.

Authors:  J M López; R Valderrama; S Navarro; S Imperial
Journal:  Int J Pancreatol       Date:  1996-02

6.  Recessive dystrophic epidermolysis bullosa: evidence for an altered collagenase in fibroblast cultures.

Authors:  E A Bauer
Journal:  Proc Natl Acad Sci U S A       Date:  1977-10       Impact factor: 11.205

7.  Purification, characterization and inhibition of human skin collagenase.

Authors:  D E Woolley; R W Glanville; D R Roberts; J M Evanson
Journal:  Biochem J       Date:  1978-02-01       Impact factor: 3.857

8.  Heparin inhibits the induction of three matrix metalloproteinases (stromelysin, 92-kD gelatinase, and collagenase) in primate arterial smooth muscle cells.

Authors:  R D Kenagy; S T Nikkari; H G Welgus; A W Clowes
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

9.  Marfan syndrome: abnormal alpha 2 chain in type I collagen.

Authors:  P H Byers; R C Siegel; K E Peterson; D W Rowe; K A Holbrook; L T Smith; Y H Chang; J C Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

10.  Heterogeneity among human collagenases demonstrated by monoclonal antibody that selectively recognizes and inhibits human neutrophil collagenase.

Authors:  K A Hasty; M S Hibbs; A H Kang; C L Mainardi
Journal:  J Exp Med       Date:  1984-05-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.